Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2025-02-28
2026-11-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurorehabilitation After Traumatic Brain Injury: Functional Magnetic Resonance Imaging Study
NCT02698449
Measuring Motor Imagery Ability in Patients With Traumatic Brain Injury.
NCT03315273
Functional Connectivity Measurement After Severe Traumatic Brain Injury
NCT02647996
The Neural Substrates for Working Memory Training
NCT03012269
Efficacy of Multidimensional Management of Mild Traumatic Brain Injury
NCT03811626
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Training sessions of rt-fMRI NF. The experimental procedure will include four training sessions of rt-fMRI NF (1/week), preceded by a localizer session for the identification of the target networks, and followed by a tranfer session where the subjects will be asked to try to self-regulate their brain activity but without receiving feedback
Cognitive remediation therapy
Cognitive remediation therapy as treatment as usual
Neuropsychological assessment
Neuropsychological assessment to measure cognitive performances
Real-time functional MRI neurofeedack (rt-fMRI NF)
Real-time functional MRI neurofeedack (rt-fMRI NF) is a procedure of brain-machine interface supporting self-regulation of brain activity, with promising results in the treatment of mental disorders. The main objective of the study is to evaluate in a pilot study, the ability of stroke patients to learn to self-regulate their brain activity in a priviledged direction.
Control group
Four fMRI sessions but without receiving feedback
Cognitive remediation therapy
Cognitive remediation therapy as treatment as usual
Neuropsychological assessment
Neuropsychological assessment to measure cognitive performances
fMRI sessions
fMRI sessions but without receiving feedback
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive remediation therapy
Cognitive remediation therapy as treatment as usual
Neuropsychological assessment
Neuropsychological assessment to measure cognitive performances
Real-time functional MRI neurofeedack (rt-fMRI NF)
Real-time functional MRI neurofeedack (rt-fMRI NF) is a procedure of brain-machine interface supporting self-regulation of brain activity, with promising results in the treatment of mental disorders. The main objective of the study is to evaluate in a pilot study, the ability of stroke patients to learn to self-regulate their brain activity in a priviledged direction.
fMRI sessions
fMRI sessions but without receiving feedback
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Right handed
* 18 ≤ years old \< 75
* first-ever ischemic stroke on brain MRI in the past 3 to 6 months ;
* Persisting cognitive complaint 3 months after the ischemic stroke, proved by a MoCA score ≤ 26 (if educational level ≥ 12 years, or ≤ 25 if educational level \< 12 years), and involving at least one of the following cognitive domains : executive functions, attention, and processing speed ;
* Ischemic stroke located in the territory of the middle cerebral artery and /or basal ganglia/thalamus ;
* NIHSS ≤ 5, without aphasia or severe visual disability empeding the understanding of the instructions, the neurofeedback task achievement, and/or the neuropsychological assessment ;
* No prestroke disability defined by a modified Rankin Scale ≤ 2 ;
* For women of childbearing potential, use of effective contraception and negative pregnancy test.
* Written informed consent by the patient.
* Coverage by the French Social Insurance
Exclusion Criteria
* History of psychiatric disorder ;
* Current use of psychotropic medication ;
* MRI contraindication ;
* Pregnancy or breastfeeding ;
* Chronic disease empeding the follow-up of the subject during the lenght of the study ;
* Non fluently-French speakers ;
* Patient under legal protection.
* Patient unable of giving personal consent
* Emergency situation
* 1st MRI incomplete, not performed or not analyzable
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharmila SAGNIER
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2023/43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.